-
Under the new policy tilt, how can MNCs increase their investment in China?
Yefenghong/PharmaSources
September 08, 2023
On August 13th, the State Council issued the "Opinions on Further Optimizing the Foreign Investment Environment and Increasing the Attractiveness of Foreign Investment" (hereinafter referred to as the "Opinions").
-
Analysis and Policy Review of Pediatric Drug Market of China
PharmaSources/Zhulikou431
May 31, 2021
As mentioned in the previous article, the U.S. is currently the largest pediatric drug market in the world, followed by China.
-
Chinese Vaccines Going Global amid Receipt of the COVID-19 Vaccines Worldwide
PharmaSources/Xiaoyaowan
February 08, 2021
The COVID-19 pandemic has circulated again recently in Europe and America, with the number of new confirmed cases hitting new highs in countries represented by the UK and the U.S., which has objectively put forward higher requirements for pandemic prevent
-
A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic
Sarah Harding
December 24, 2020
China has been viewed in recent years as a ‘rising star’ of the pharma industry. Notwithstanding political pressures – primarily from the US – founded on concerns over China’s growing dominance in the field.
-
The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later
Lin Zhang
December 24, 2020
The Human Genome Project (HGP) is the first and greatest endeavor so far to understand ourselves and all other types of life through the vast international collaboration.
-
Discovering Biotechnology: Top 9 Chinese Pharmaceutical Companies in 2020
Deborah Seah
November 04, 2020
China 's pharmaceutical industry garnered a total revenue of about 2.6 trillion yuan in 2019 amounting to an eight percent year-on-year growth.
-
How AI is Redefining the Pharmaceutical Industry in China
Neeta Ratanghayra
October 22, 2020
Artificial intelligence (AI) refers to the use of automated algorithms to perform the tasks conventionally done with human intelligence.
-
The Second CAR-T Therapy in China Applied for Marketing
PharmaSources/Dopine
July 01, 2020
On June 30, according to the official website of CDE, the marketing application of a CAR-T therapy, JWCAR029 by JW Therapeutics was accepted by CDE.
-
Pharmaceutical News of the Week (June.22-27) | PharmaSources.com
PharmaSources/Caicai
July 01, 2020
With the last week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 22-28, including 22 pieces.
-
China Disclosed Research Data of PiCoVacc, an Inactivated Virus Vaccine against COVID-19
CPhI.CN
April 21, 2020
On April 19, the Chinese Academy of Medical Sciences uploaded an article entitled "Rapid development of an inactivated vaccine for SARS-CoV-2" in BioRxiv.